Home Healthcare Pharmaceuticals Ophthalmic Drugs Market

Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Anti-allergy, Anti-inflammatory, Non-steroidal drugs, Steroidal drugs, Anti-VEGF Agents, Others), By Disease Type (Dry eye, Allergies, Glaucoma, Uveitis, Other retinal disorders), By Dosage Form (Gels, Eye Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Ophthalmic Drugs Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Anti-allergy
    2. Anti-inflammatory
    3. Non-steroidal drugs
    4. Steroidal drugs
    5. Anti-VEGF Agents
    6. Others
  2. Ophthalmic Drugs Market, By Disease Type 2022-2034 (USD MILLION/ Units)
    1. Dry eye
    2. Allergies
    3. Glaucoma
    4. Uveitis
    5. Other retinal disorders
  3. Ophthalmic Drugs Market, By Dosage Form 2022-2034 (USD MILLION/ Units)
    1. Gels
    2. Eye Solutions & Suspensions
    3. Capsules and Tablets
    4. Eye Drops
    5. Ointments
  4. Regional Ophthalmic Drugs Market
    1. North America
      1. North America Ophthalmic Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
      2. North America Ophthalmic Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Dry eye
        2. Allergies
        3. Glaucoma
        4. Uveitis
        5. Other retinal disorders
      3. North America Ophthalmic Drugs Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Gels
        2. Eye Solutions & Suspensions
        3. Capsules and Tablets
        4. Eye Drops
        5. Ointments
      4. U.S.
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      5. Canada
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
    2. Europe
      1. Europe Ophthalmic Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
      2. Europe Ophthalmic Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Dry eye
        2. Allergies
        3. Glaucoma
        4. Uveitis
        5. Other retinal disorders
      3. Europe Ophthalmic Drugs Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Gels
        2. Eye Solutions & Suspensions
        3. Capsules and Tablets
        4. Eye Drops
        5. Ointments
      4. U.K.
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      5. Germany
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      6. France
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      7. Spain
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      8. Italy
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      9. Russia
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      10. Nordic
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      11. Benelux
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      12. Rest of Europe
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
    3. APAC
      1. APAC Ophthalmic Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
      2. APAC Ophthalmic Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Dry eye
        2. Allergies
        3. Glaucoma
        4. Uveitis
        5. Other retinal disorders
      3. APAC Ophthalmic Drugs Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Gels
        2. Eye Solutions & Suspensions
        3. Capsules and Tablets
        4. Eye Drops
        5. Ointments
      4. China
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      5. Korea
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      6. Japan
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      7. India
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      8. Australia
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      9. Taiwan
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      10. South East Asia
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      11. Rest of Asia-Pacific
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
    4. Middle East and Africa
      1. Middle East and Africa Ophthalmic Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
      2. Middle East and Africa Ophthalmic Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Dry eye
        2. Allergies
        3. Glaucoma
        4. Uveitis
        5. Other retinal disorders
      3. Middle East and Africa Ophthalmic Drugs Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Gels
        2. Eye Solutions & Suspensions
        3. Capsules and Tablets
        4. Eye Drops
        5. Ointments
      4. UAE
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      5. Turkey
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      6. Saudi Arabia
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      7. South Africa
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      8. Egypt
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      9. Nigeria
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      10. Rest of MEA
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
    5. LATAM
      1. LATAM Ophthalmic Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
      2. LATAM Ophthalmic Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Dry eye
        2. Allergies
        3. Glaucoma
        4. Uveitis
        5. Other retinal disorders
      3. LATAM Ophthalmic Drugs Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Gels
        2. Eye Solutions & Suspensions
        3. Capsules and Tablets
        4. Eye Drops
        5. Ointments
      4. Brazil
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      5. Mexico
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      6. Argentina
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      7. Chile
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      8. Colombia
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
      9. Rest of LATAM
        1. Anti-allergy
        2. Anti-inflammatory
        3. Non-steroidal drugs
        4. Steroidal drugs
        5. Anti-VEGF Agents
        6. Others
        7. Dry eye
        8. Allergies
        9. Glaucoma
        10. Uveitis
        11. Other retinal disorders
        12. Gels
        13. Eye Solutions & Suspensions
        14. Capsules and Tablets
        15. Eye Drops
        16. Ointments
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.